ArticleInternational journal of molecular sciences2026
Pomegranate Peel Extract Alleviates Psoriasis-like Skin Lesions in Mice Through the Suppression of AhR-Activating Th17/IL-17 Axis and Neuronal-Related Pathways.
Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Psoriasis is a refractory skin disease that is often accompanied by systemic comorbidities. While the efficacy of biologics in treating psoriasis is well-established, these treatments are also associated with frequent adverse reactions. Consequently, there is an urgent need to develop new treatment strategies for psoriasis. Pomegranate peel, which is widely used in skincare and protection, has not been fully studied for its therapeutic potential in psoriasis. This article investigates the therapeutic effectiveness of pomegranate peel ethanol extract (PEE) on psoriasis. A total of 2872 compounds were identified in PEE. The topical application of PEE alleviated primary psoriasis-like skin lesions and reduced lesion recurrence in mice. PEE simultaneously activates AhR and inhibits the Th17/IL-17 axis and neuronal-related pathways, which may serve as a mechanism for PEE in the treatment of psoriasis. In conclusion, our study establishes that PEE may serve as a novel therapeutic agent for psoriasis, with a unique mechanism of action that simultaneously activates AhR and suppresses neuronal-related pathways.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.